# Organization Program of DiabEtes INsulIN ManaGement

> **NCT01338376** · PHASE4 · UNKNOWN · sponsor: **Chinese Diabetes Society** · enrollment: 1500 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **BEHAVIORAL:** Structured Education
- **BEHAVIORAL:** Conventional Diabetes Education
- **DRUG:** Scilin®M30

## Key facts

- **NCT ID:** NCT01338376
- **Lead sponsor:** Chinese Diabetes Society
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-05
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2011-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338376, "Organization Program of DiabEtes INsulIN ManaGement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01338376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*